02/24/2026
Congratulations!
February 23, 2026
Fabiola Arbelo Cruz, MD, has been appointed medical director of the Substance use and Addiction Treatment Unit (SATU) at the Connecticut Mental Health Center (CMHC) effective July 1.
Dr. Arbelo Cruz is an assistant professor of psychiatry, director of the Health Equity Curriculum of the Yale Psychiatry Residency Program, and serves as an attending psychiatrist on CMHC’s Team D and Street Psychiatry outpatient teams. She brings extensive frontline clinical experience in co-occurring mental illness and substance use disorders (SUD), having worked in community health centers and addiction programs in Boston and New Haven.
Dr. Arbelo Cruz has received multiple awards in recognition of her leadership, clinical excellence, and commitment to advancing the field of addiction and guiding the next generation of addiction medicine leaders. She has been recognized by the American Academy of Addiction Psychiatry (AAAP) with its John Renner Award, the Boston University Department of Psychiatry with its Chairman’s Award, and has been selected as a Scholar (2020) and Near Peer (2025) in the Recognizing and Eliminating Disparities in Addiction Through Culturally-informed Healthcare (REACH) Program.
Dr. Arbelo Cruz’s clinical and research interests focus on critically evaluating and disseminating knowledge on evidence-based practices for SUD, stigma related to SUD and its treatments, and addressing racial and ethnic inequities in addiction treatment. She serves as a study physician for the IMANI U randomized controlled trial. The trial examines whether adding a church-based telehealth medication for addiction treatment option to the IMANI Breakthrough program improves outcomes for individuals residing in geographic areas with high overdose rates who have alcohol use disorder or opioid use disorder, compared to IMANI Breakthrough plus traditional community-based MAT referral and linkage.
Dr. Arbelo Cruz also serves as an active member of several national and institutional committees, including the AAAP Health Access Committee, CMHC’s Health Equity Workgroup, and the Yale Psychiatry Residency Realignment Working Group – Faculty Development Subcommittee.
Sincerely,
Jeanne
Jeanne Steiner, DO
Professor of Psychiatry
Medical Director, CMHC
Director, Fellowship in Public Psychiatry